Task order under contract HHSN275200403369 - task 4, order HHSN275201000080U, single dose, dose-ranging and 28 days repeat-dose safety and tolerability, pharmacokinetics, and pharmacodynamics study of…

Ended Awarded

Contract number
HHSN275201100076U
Awardee
Awarding agency
Obligated
$241,128

Award facts

Opportunity
  • RFPNICHD200305 Solicitation number
Contract value 100% obligated
$241,128.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
Not on record
PSC
AN12 Health R&D Services; Health Care Services; Applied Research
Set-aside
Total Small Business
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Torrance, CA, USA

Award details come from SAM.gov/FPDS.

Description

Task order under contract HHSN275200403369 - task 4, order HHSN275201000080U, single dose, dose-ranging and 28 days repeat-dose safety and tolerability, pharmacokinetics, and pharmacodynamics study of dimethandrolone undecanoate (DMAU) in healthy men

Quick answers

Who was awarded contract HHSN275201100076U?

HHSN275201100076U was awarded to Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center by National Institute of Child Health and Human Development (National Institutes of Health) on March 31, 2011.

How much is contract HHSN275201100076U worth?

The government has obligated $241,128 on HHSN275201100076U.

Is contract HHSN275201100076U an order under another contract?

Yes. HHSN275201100076U is a delivery order under HHSN275200403369I, an indefinite delivery contract.

Was contract HHSN275201100076U competed?

The extent of competition for HHSN275201100076U was full and open competition. The government received 1 offer. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award